Jubaan
Jubaan Ltd. is a MedTech company revolutionizing colorectal cancer diagnostics with its Gixam™ system, a low-cost, non-invasive pre-screening tool that uses deep learning and artificial intelligence to detect the probability of colorectal adenomas. The system offers operational simplicity by allowing patients to be screened quickly and easily during a routine doctor's visit through tongue snapshots, providing instantaneous results to support healthcare providers in decision-making. Clinical trials are ongoing in prestigious institutions in the USA, Israel, and Europe, positioning Jubaan as an innovative player in gastrointestinal disorder diagnostics.
Jubaan
Jubaan Ltd. is a MedTech company revolutionizing colorectal cancer diagnostics with its Gixam™ system, a low-cost, non-invasive pre-screening tool that uses deep learning and artificial intelligence to detect the probability of colorectal adenomas. The system offers operational simplicity by allowing patients to be screened quickly and easily during a routine doctor's visit through tongue snapshots, providing instantaneous results to support healthcare providers in decision-making. Clinical trials are ongoing in prestigious institutions in the USA, Israel, and Europe, positioning Jubaan as an innovative player in gastrointestinal disorder diagnostics.